TransMedics Group, Inc. — Director's Dealing 2019

May 2, 2019

SEC Form 3 — Initial Statement of Beneficial Ownership

Issuer: TransMedics Group, Inc. (TMDX)
CIK: 0001756262
Period of Report: 2019-05-01

Reporting Person: Weill David (Director)

Holdings (Derivative)

Security	Exercise Price	Expiration	Underlying	Shares	Ownership
Stock Option (Right to Buy)	$16.00	2029-05-01	Common Stock (21645)		Direct

Footnotes

F1: This option was issued pursuant to the TransMedics Group, Inc. 2019 Stock Incentive Plan to purchase shares of common stock of the Issuer. The option vests as to one-third of the shares subject to the option on the first anniversary of the grant date, May 1, 2019, and in equal monthly installments as to the remainder of the shares for two years thereafter.